Manitoba Health s Diagnostic and Surgical Recovery Task Force has launched a new process for individuals currently waiting for diagnostic sleep testing to find out if they are eligible for an in-home alternative.
The FDA has authorized marketing of Cerebra Medical Ltd’s Cerebra Sleep System, a type II and III home sleep testing device with a patented sleep depth algorithm.